Compare INO & CYPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INO | CYPH |
|---|---|---|
| Founded | 1979 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.6M | 155.8M |
| IPO Year | 1998 | N/A |
| Metric | INO | CYPH |
|---|---|---|
| Price | $1.75 | $1.29 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | 1.7M | ★ 6.9M |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $182,337.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $21,214.02 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.30 | $0.22 |
| 52 Week High | $2.98 | $3.70 |
| Indicator | INO | CYPH |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | N/A |
| Support Level | $2.11 | N/A |
| Resistance Level | $2.37 | N/A |
| Average True Range (ATR) | 0.19 | 0.00 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 6.16 | 0.00 |
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.